Mon, Jul 28, 2014, 6:02 AM EDT - U.S. Markets open in 3 hrs 28 mins

Recent

% | $
Click the to save as a favorite.

Achillion Pharmaceuticals, Inc. (ACHN) Message Board

magnam_pi 293 posts  |  Last Activity: Jul 27, 2014 12:50 AM Member since: Dec 11, 2001
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Buyout ain't happening with ACHN

    by sidelurker Jul 26, 2014 11:44 AM
    magnam_pi magnam_pi Jul 27, 2014 12:50 AM Flag

    Who said "buyout ain't happening"? Whoever said that is greyed out and on ignore on my screen ... for a reason ... their posts are worthless ...

    I can say with 100% certainty that ACHN is a prime buyout candidate ... for its nuke ACH 3422 now in Phase 1 trials with results due this fall ... all the info out there points to 3422 being just as safe and efficacious as Gilead's sovaldi which just turned in $3.3 BILLION in revenue for the second quarter as reported on Friday ... it beat all forecasts ... Gilead paid $11 billion to acquire Pharmaset for sovaldi, Merck paid $3.85 billion to acquire Idenix for its nuke 21437 in June ... the same will happen with ACHN ... it will be bought out at $40-100 pps for 3422 ... the writing is on the wall ... 3422 will be a success story ... and shorties will be history ...

  • Reply to

    Just Off Topic

    by macugen_rules Jul 25, 2014 6:08 PM
    magnam_pi magnam_pi Jul 26, 2014 10:57 AM Flag

    I just posted a comment under "frontiers" at gefvert's article --

    "
    Good to know that Yahoo Finance will not be carrying the articles from Seeking Alpha in their headlines stream any more as of next week ... this article was written by a self-styled "expert" with little real knowledge of biotechs and meant to deliberately mislead with the purpose of supporting author's short position in the stock ... it's articles like this one that finally convinced Yahoo to kick SA off their headlines stream ... well done Yahoo!!!!
    "

  • Reply to

    Just Off Topic

    by macugen_rules Jul 25, 2014 6:08 PM
    magnam_pi magnam_pi Jul 25, 2014 6:46 PM Flag

    Good news for sure. I posted a bunch of comments on gefvets article in June and he had no good response. I told him to stick to his own area of expertise and stop posting about biotech which he's clue less about. Sa has been mis used by gefvet and others ,,,

  • Reply to

    tug of war

    by edgautr Jul 25, 2014 3:24 PM
    magnam_pi magnam_pi Jul 25, 2014 3:38 PM Flag

    Well, the real problem for the shorties is that they don't care to know or understand the facts that are stacked up against them and keep building up ... they are dreaming about a slide to $3 ... all they have is their hopes and prayers ... all they will get soon is nightmares ...

  • Reply to

    News from ACHN expected in the next few weeks ...

    by magnam_pi Jul 25, 2014 11:53 AM
    magnam_pi magnam_pi Jul 25, 2014 2:50 PM Flag

    Thanks for your post ... the recent 1625 clinical hold lift wasn't worth $8-8.5, many people would say ... but it did get there ... I have little doubt the pps will glide well past $8 on the SVR4 news ... a short squeeze will be engineered to deliver a pps of at least $10 ... the shorties here will lose ... and if they persist and hold into 3422 news, they will lose much MUCH more ... I have no doubt ...

  • Reply to

    2nd leg down about to form......

    by sidelurker Jul 25, 2014 1:58 PM
    magnam_pi magnam_pi Jul 25, 2014 2:30 PM Flag

    Is the moron still posting his garbage ? He's ignorant stupid and a poor trader to boot. They say a fool is one doesn't know and doesn't know that he doesn't know. It fits him well ...

  • ACHN will report the SVR4 from the 8-week 3102 + sovaldi trial soon ... the CEO mentioned during a recent investor conference (JMP ?) that it will be reported in August ... if the SVR4 is 100% (which I expect it will be), they will start a 6 week trial ... in future they could also add a PI (2684) to produce a more robust response and shorter cure times ... yes, lot of irons in the fire ... and shorties are gonna get the hot iron treatment soon ... with promise of lots more to come ...

    I expect to see pps glide up to the 10-13 range on the SVR4 news ... if anyone has other guesses on pps after SVR4 news, please post ...

  • Reply to

    Shorts Destroyed

    by edgautr Jul 25, 2014 11:24 AM
    magnam_pi magnam_pi Jul 25, 2014 11:31 AM Flag

    yes, shorts here will be slaughtered ... financially that is ... its interesting that they have no idea what's in store for them ... but if they dare to hold their short positions into 3422 news, they will find out ... too late of course ...

  • Reply to

    HCV market size and ACHN

    by magnam_pi Jul 24, 2014 11:30 AM
    magnam_pi magnam_pi Jul 25, 2014 10:55 AM Flag

    Take a look at the presentations of June and May at the website ... as well as the transcript of the May CC from Seeking Alpha ... you will find the 3422 pre-clinical info there ...

  • Reply to

    HCV market size and ACHN

    by magnam_pi Jul 24, 2014 11:30 AM
    magnam_pi magnam_pi Jul 25, 2014 10:11 AM Flag

    Yes, its Phase 1 data ... IDIX was acquired for its nuke 21437 for $3.8 billion after a successful Phase 1 ... I expect the same will happen here ... 3422 is a safe and efficacious drug ... it will be very similar to Gilead's sovaldi in its properties ... there are some very ignorant people posting nonsense about ACHN here and they will be in for the shock of their lives when the 3422 news hits the wires ...

  • Reply to

    sidejerkers boss

    by edgautr Jul 24, 2014 6:39 PM
    magnam_pi magnam_pi Jul 24, 2014 8:46 PM Flag

    Final ah trade was 7.33

  • Reply to

    The great predictor

    by edgautr Jul 24, 2014 11:34 AM
    magnam_pi magnam_pi Jul 24, 2014 11:48 AM Flag

    The ignorant shorties here have not caught on to what's happening ... biotechs took a hit on the heels of the yellin' remarks at the Fed ... some good ones including ACHN, AGEN, EXEL all took a hit with wall street manipulation as usual ... it was a good time to add ... and I did ... the affected biotechs are all rebounding today ... ACHN in particular has a lot of news in the offing and a potential buyout ... you can bet that the wall street manipulators know about this very well, better than you or me ... it's the shortie fools who do not ...

  • With the size of the HCV market ... 150 million patients worldwide, 3 million in the US ... Gilead sovaldi treatment price $84,000 per patient ... US market alone worth 3 million x $84000 or $250 billion! ... Gilead is treating ~100,000 patients a year ... or 3% of US patient population per year ... leaves the US market wide open for other players to step in ... almost ANY big pharma you can think of will be a potential bidder for ACHN after the 3422 trial news ... which I expect will show 3422 to equal or surpass sovaldi in efficacy and safety ... the low end of the bidding will start at $3.85 billion which was the IDIX buyout price or ~$40 pps ...

  • Reply to

    question for macugen / magnum pi

    by quishayk Jul 23, 2014 1:50 PM
    magnam_pi magnam_pi Jul 23, 2014 3:55 PM Flag

    P.S.

    On the 3422 trial, ACHN has said they will report the results in early fall ... which I take to mean before Nov 10.

  • magnam_pi magnam_pi Jul 23, 2014 2:42 PM Flag

    u are on the right track, my friend ...

  • Reply to

    question for macugen / magnum pi

    by quishayk Jul 23, 2014 1:50 PM
    magnam_pi magnam_pi Jul 23, 2014 2:40 PM Flag

    achn has said they will report the results of the trial 3102/ sovaldi during the summer ... they will not report the results piecemeal ,,, but all at one time ... which to me means they will report the results of 6 week and 8 week at the same time ,,, I expect they will report the results in August ...

  • Reply to

    Achn-3422 has ip? I dont think so

    by bergycb Jul 23, 2014 6:40 AM
    magnam_pi magnam_pi Jul 23, 2014 9:17 AM Flag

    As I said these guys are stupid and ignorant ..

  • Reply to

    Shorties

    by macugen_rules Jul 22, 2014 11:06 PM
    magnam_pi magnam_pi Jul 23, 2014 12:25 AM Flag

    Should be fun to watch that show ... it will be coming soon to ACHN too ... of that, I have no doubt ... I have these clowns on ignore because they are so stupid ... but I will un-ignore them when the 3422 news is out ... just to add to all the fun ...

  • Reply to

    Here's an example calculation ....

    by magnam_pi Jul 22, 2014 10:30 AM
    magnam_pi magnam_pi Jul 22, 2014 1:01 PM Flag

    I see a greyed out reply to my post ... sorry I can't read it because ur on ignore ... and if I did put u on ignore, it was for a reason ... I don't value anything u have to say ...

  • magnam_pi magnam_pi Jul 22, 2014 11:57 AM Flag

    Bidders for IDIX in order ...
    (1) Merck $24.50 winning bid
    (2) Abbvie $19.75 final offer (Party A in IDIX filing)
    (3) Bristol Myers Squibb (Party B)
    (4) J & J (Party C)
    (5) Novartis ... did not bid

    The same parties (as well as others) are likely bidders for ACHN after 3422 news.

    There are 150 million HCV patients word-wide, 3 million in the US ... $84000 per patient GILD pricing ... US market is worth $250 billion!!! ... GILD is treating ~100,000 patients a year with sovaldi ... or ~3% of the US patient population per year ... if not treated, HCV leads to liver disease worsening and need for transplant ... huge healthcare costs which can be avoided by treatment ... FDA is anxious to get new HCV drugs approved and have more than one player in the market ... NS5B nucleoside inhibitor needs to part of the drug combo used ... at present ACHN is the only independent biotech with a nuke in the clinic ... almost every big pharma you can think of will want to grab it ... think about that ...

ACHN
7.22-0.08(-1.10%)Jul 25 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Puma Biotechnology, Inc.
NYSEFri, Jul 25, 2014 4:01 PM EDT
Sohu.com Inc.
NasdaqGSFri, Jul 25, 2014 3:59 PM EDT